Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biomedicines|July 27, 2024
Amantadine for Traumatic Brain Injury-Supporting Evidence and Mode of ActionAndrzej Dekundy, Gerald Pichler, Reda El Badry, et al.
Toxicology and Applied Pharmacology|July 21, 2009
Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidenceElzbieta Zielińska, Damian Kuc, Wojciech Zgrajka, et al.
Brain Research Bulletin|March 28, 2006
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's diseaseAndrzej Dekundy, Malgorzata Pietraszek, Daniela Schaefer, et al.
Advances in Therapy|August 12, 2020
IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled TrialDimos D Mitsikostas, Andrzej Dekundy, Kati Sternberg, et al.
Neurobiology of Disease|August 21, 2018
Rescue of Fmr1KO phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056Pamela R Westmark, Andrzej Dekundy, Andreas Gravius, et al.
Polish Journal of Pharmacology|January 6, 2004
Deficit of endogenous kynurenic acid in the frontal cortex of rats with a genetic form of absence epilepsyRafał M Kamiński, Elzbieta Zielińska, Andrzej Dekundy, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 2008
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in ratsAndreas Gravius, Andrzej Dekundy, Jens Nagel, et al.
Toxicology|January 25, 2005
Carbofuran-induced oxidative stress in slow and fast skeletal muscles: prevention by memantine and atropineDejan Milatovic, Ramesh C Gupta, Andrzej Dekundy, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2009
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalingDaniella Rylander, Alessandra Recchia, Flora Mela, et al.
Neuropharmacology|March 28, 2006
mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsyWolfgang Löscher, Andrzej Dekundy, Jens Nagel, et al.
Pageof 4